Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.53 |
| ▸ | CMA1 | P23946 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7235100 | 0.90 | TAAR1 (0.57) | TAAR1CYP3A4CYP1A2MAPTTRPV1 | |
| SCHEMBL6061509 | 0.89 | TAAR1 (0.47) | TAAR1CYP3A4CYP1A2MAPTTRPV1 | |
| SCHEMBL230807 | 0.88 | HDAC1 (0.57) | TAAR1CYP3A4CYP1A2MAPTTRPV1 | |
| SCHEMBL27611447 | 0.87 | HDAC1 (0.56) | TAAR1CYP3A4CYP1A2MAPTTRPV1 | |
| SCHEMBL9706198 | 0.84 | TAAR1 (0.51) | TAAR1CYP3A4CYP1A2MAPTTRPV1 | |
| SCHEMBL27559672 | 0.84 | HDAC1 (0.54) | TAAR1CYP3A4CYP1A2MAPTTRPV1 | |
| SCHEMBL30194501 | 0.83 | CYP3A4 (0.70) | TAAR1CYP3A4CYP1A2MAPTCMA1 | |
| SCHEMBL406700 | 0.83 | CYP3A4 (0.70) | TAAR1CYP3A4CYP1A2MAPTCMA1 | |
| SCHEMBL108087 | 0.82 | TAAR1 (0.77) | TAAR1CYP3A4CYP1A2MAPTCALM1 | |
| SCHEMBL8076160 | 0.82 | CYP3A4 (0.69) | TAAR1CYP3A4CYP1A2MAPTTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322182-A | Azole antifungal compound and application thereof | 广西医科大学 | 2022-11-11 | — | — | CN | claimed |
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| EP-3262148-B1 | A SYNERGISTIC PERFUMING COMPOSITION | FIRMENICH & CIE (CH) | 2018-11-07 | — | — | EP | claimed |
| CN-107923120-A | Composition for reducing malodour and use thereof | 阿吉莱克斯香料和香水公司 | 2018-04-17 | — | — | CN | claimed |
| US-9814661-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-14 | — | — | US | claimed |
| EP-2961374-B1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | claimed |
| EP-2961374-A1 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2016-01-06 | — | — | EP | claimed |
| WO-2015089246-A1 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-18 | — | — | WO | claimed |
| US-20150164764-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-06-18 | — | — | US | claimed |
| CN-103874675-A | Process for the preparation of methoxymelonal | GIVAUDAN SA | 2014-06-18 | — | — | CN | claimed |
| WO-2001023274-A1 | DETERGENT PACKAGE WITH MEANS TO MASK AMINE MALODOURS | THE PROCTER & GAMBLE COMPANY (US) | 2001-04-05 | — | — | WO | claimed |
| EP-0215622-A2 | Naphthalene anti-psoriatic agents and process for making them | SYNTEX (U.S.A.) INC. (US) | 1987-03-25 | — | — | EP | claimed |
| EP-3881048-B1 | DEVICE FOR REMOVING VOLATILE ORGANIC COMPOUNDS | LETAT FRANCAIS REPRESENTE PAR LE MINI DE LINTERIEUR (FR) | 2026-05-06 | — | — | EP | disclosed |
| US-12466775-B2 | Visible-light mediated organophotoredox catalytic deuteration of aromatic and aliphatic aldehydes | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-11-11 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20240287406-A1 | FRAGRANCE COMPOSITION | COTY INC. | 2024-08-29 | — | — | US | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-4020060-A | ANTIBACTERIAL, ANTIBIOTICS | RICHARDSON-MERRELL INC. (US) | 1977-04-26 | — | — | US | disclosed |
| US-3994877-A | 6-[α-AMINO-ω-(3,4-METHYLENEDIOXYPHENYL)ACYLAMIDO]PENICILLANIC ACID DERIVATIVES | RICHARDSON-MERRELL INC. (US) | 1976-11-30 | — | — | US | disclosed |
| US-3962415-A | Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer | AIRWICK INDUSTRIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150164764-A1 | Fragrance Compositions | OGG1, ALKBH5, MYB | TAAR1 2729/4885CYP3A4 1406/4885CYP1A2 1956/4885 |
| US-12466775-B2 | Visible-light mediated organophotoredox catalytic deuteration of aromatic and aliphatic aldehydes | AOX1, TDO2, TALDO1 | TAAR1 1157/4885CYP3A4 174/4885CYP1A2 203/4885 |
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | TAAR1 1032/4885CYP3A4 1049/4885CYP1A2 483/4885 |
| US-20240287406-A1 | FRAGRANCE COMPOSITION | FAAH2, FAAH, C1S | TAAR1 356/4885CYP3A4 936/4885CYP1A2 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.